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The carcinogenic hydrocarbons have been very extensively studiedfrom several
different points of view. Many problems still await solution, but the relationship
between chemical constitution and carcinogenic activity is becoming clearer
(Badger, 1948; Pullman and Pullman, 1955). The azo-compounds have also
received considerable attention, and here again some relationship between
structure and activity is discernible (Badger, and Lewis, 1952; Pullman and
Pullman, 1955). Examples of chemical carcinogens belonging to other classes of
compound are also known, and in recent years more attention has been devoted
to these substances. Certain aromatic amines are carcinogenic as well as some
urethanes, chloro-compounds, "mustards ", ethyleneimines, Senecio alkaloids,
steroids, and some inorganic compounds. The purpose of the present paper is
to review the present position with these miscellaneous chemical carcinogens.
Radioactive carcinogens and hormonal carcinogens (oestrogens, etc.) are not
included.
The diversity ofthe different types of chemical carcinogen may occasion some
surprise. On the other hand, different chemical types are well known to produce
many other biological responses. Antibacterial drugs, for example, vary widely in
their chemical type, and in their mode ofaction. In this case it is clearly unprofit-
able to attempt to find structural relationships between compounds acting by
entirely different mechanisms; but the study ofthe relationship between chemical
constitution and antibacterial activity among any one group (say the sulphona-
mides) maybeusefulandvaluable. Inthe samewaythe different types ofchemical
carcinogens probably have different modes of action. In these circumstances no
structural relationship between the polycyclic aromatic hydrocarbons, the ethyl-
eneimines, urethane and carbon tetrachloride, should be looked for. Nevertheless,
the study of carcinogenic activity in a series of related aromatic amines may
produce information of some importance, as may a similar study of a series of
related ethyleneimines, and so on. It should be noted, however, that an observed
structural relationship does not necessarily establish that two compounds produce
the same biological action by the same mechanism. Most of the sulphonamides
probably do have the same mode ofaction, but in spite ofits structural similarity,
p-sulphonamidobenzylamine is known to differfromsulphanilamide. Furthermore,
among the carcinogenic azo-compounds, evidence is accumulating that compounds
such as 1-phenylazo-2-naphthol and 2: 2'-azonaphthalene should be clearly
distinguished from the amino-azo-compounds such as 4-dimethylaminoazo-
benzene (Badger, Lewis and Reid, 1954).CHEMICAL CONSTITUTION AND CARCINOGENESIS
INORGANIC CARCINOGENS
Arsenic
For many years the prolonged exposure to small quantities of arsenic, either
in the drinking water, by industrial exposure, or by treatment with arsenical
drugs, has been thought to be a contributing factor in certain varieties of cancer
(Hueper, 1942, 1954). Much of the early evidence was clearly unsatisfactory,
and it is still incomplete, but the general consensus ofopinion now seems to be that
arsenic must be classed as an exogenous carcinogen having a low order ofpotency
(see however Snegireff and Lombard, 1951). A few cases ofoccupational arsenical
cancer have been noted in factories manufacturing sheep-dip preparations
(sodium arsenite, and arsenious acid) and insecticides (copper arsenite, calcium
arsenate, or lead arsenate), and a very few in the mining and smelting industry.
The literature has been carefully reviewed by Neubauer (1947).
A number of cases of "medicinal" arsenical cancer have also been reported
in patients treated with various inorganic arsenical drugs such as potassium
arsenite and arsenic trioxide. Neubauer collected 143 such cases from the litera-
ture, butmorehavesincebeenreported (e.g.ArhelgerandKremen, 1951; Robertson
and Clement, 1948; Putman, 1945).
The most important trivalent arsenical drugs are the arsphenamines, used for
the treatment ofsyphilis, and Neubauer concludes that these play only an insigni-
ficant part in the causation of cancer.
There have been several attempts to produce arsenical cancers in laboratory
animals, but no satisfactory evidence of success has been produced. Part of the
difficulty is probably associated with the toxic nature ofthe material; otherwise it
must be tentatively assumed that man is more susceptible to arsenic than the
laboratory animals used so far.
Beryllium
The production of osteogenic sarcomas in rabbits'following the injection of
zinc beryllium silicate and beryllium oxide was first noted by Gardner and
Heslington (1946), and has since been confirmed by many other workers (Barnes,
1950; Nash, 1950; Hoagland, Grier and Hood, 1950; Dutra and Largent, 1950;
Barnes, Denz and Sissons, 1950, Sissons, 1950).
An osteogenic sarcoma has been reported following the inhalation ofberyllium
oxide (Dutra, Largent and Roth, 1951) and finely powdered beryllium metal has
also been shown to be effective when administered by intravenous injection as an
aqueous suspension (Barnes, 1950).
This experimental production of tumours using beryllium and beryllium
compounds is of considerable importance in view of the industrial use of these
materials. Among workers in the industry, pulmonary reactions and skin lesions
appear to be common, and subcutaneous granuloma have been reported in persons
who cut themselves on fluorescent lamps containing beryllium (Van Ordstrand,
Hughes, DeNardi and Carmody, 1945; Grier, Nash and Freiman, 1948).
Chromium
Several workers have reported that the incidence of cancer of the lung is
significantly higher among workers in the chromate industry than in comparable
groups not exposed to compounds of this metal (Machle and Gregorius, 1948;
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Baetjer, 1950; Bourne and Yee, 1950; Bidstrup, 1950, 1951; Mancuso and
Hueper, 1951). It would seem therefore that chromium must be added to the list
of inorganic carcinogens and further experimental work to determine the exact
nature of the carcinogen is urgently required.
Cobalt
Tumours at the site ofinjection have been produced following the administra-
tion of pure 400-mesh cobalt powder (mixed with fowl serum) to rats of the
hooded strain (Heath, 1954).
Nickel
Hueper (1952) has reported the production of a number of cancers in rats
following the injection of nickel powder in lanolin. Most of the tumours were
apparently osteogenic sarcomas, but one originated from connective tissue at the
site ofinjection, one from the epithelial lining of an osteomyelitic fistula, and two
seemed to have developed from abdominal lymph nodes. The minimum latent
period was about six months.
It may be noted that men working in the Mond nickel process show a high
incidence of cancer of the lung and of the nasal passages (Bidstrup, 1950).
Zinc
Zinc chloride has been found to produce teratoma of the testis in a small
percentage of cases following injection into the testes of adult roosters (Bagg,
1936; Anissimova, 1939; Michalowsky, 1928). Zinc sulphate behaves similarly
(Falin and Gromzewa, 1939).
General survey of inorganic carcinogens
Tumours have sometimes been attributed to the non-specific action of such
substances as hydrochloric acid and sodium hydroxide (Narat, 1925; Suntzeff,
Babcock and Loeb, 1940). Tumours have also beenproduced following the admini-
stration of various radioactive substances, and it is generally assumed (but
without adequate evidence) that the carcinogenic action is due to the radiations
emitted. For example, the injection ofpowdered metallic uranium (a pure alpha-
ray emitter) into 33 rats resulted in the development of 11 sarcomas at the site of
injection; but it is not known whether this is a metallo-carcinogenic effect or a
radio-carcinogenic effect (Hueper, Zuefie, Link and Johnson, 1952).
As far as can be judged, however, the carcinogenic action of the inorganic
substances mentioned in the sections above is a specific one; but there seems
to be no knowledge of their mode of action. As a workinghypothesis, however, it
may be worth noting that (with the exception of beryllium, the carcinogenic
activity of which is highly specialised) all these elements would be expected to
combine with sulphur groups in certain enzymes and proteins, etc., and such an
interference might well initiate the carcinogenic process. In this respect, therefore,
the inorganic ions may well resemble the carcinogenic hydrocarbons in their mode
of action. The reactivity ofvarious metal ions towards sulphur groups is reflected
in their action towards substances such as BAL, penicillin, etc. For example,
BAL is effective against arsenic, mercury, nickel, cadmium, chromium, antimony
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and some others (Thompson and Whittaker, 1947; Graham and hood, 1948;
Russell, Green and Wand, 1948).
The present list ofinorganic carcinogens is unlikely to be complete, and indeed
there is a brief reference to the possible carcinogenic activity of tin (Larionov,
1930). Clearly further work is required in this field.
AROMATIC AMINES
"Aniline cancer"
In 1895 Rehn reported three cases of bladder tumour occurring among men
engaged ifi the manufacture of fuchsine (magenta). As the number of workmen
involved was small, he thought this was an undue incidence and he regarded the
tumours as of occupational origin. The aniline used in the manufacturing process
was suggested as the most probable carcinogen.
Further cases of bladder tumours occurring in dyestuffs operatives were soon
reported by other workers. Hueper (1938) estimated the total number ofrecorded
cases of this type of occupational cancer as 550; but the actual number was
doubtless greater than this. More recently, Case, Hosker, McDonald and Pearson
(1954) have stated that 455 cases ofbladder tumour have been found in the British
chemical industry up to February 1, 1952; of these, 444 were found in and after
1921, the first year in which death certificates were available for systematic
search.
In many of the early investigations aniline often seemed to be implicated, and
this form of occupational cancer came to be known as "aniline cancer ". Within
the last few years, however, athorough statisticalexamination has been completed,
and no evidence was found that aniline causes an increased number of bladder
tumours in men who manufacture or handle it (Case, Hosker, McDonald and Pear-
son, 1954). On the other hand, it must be remembered that the aniline used in
the chemical industry today is a fairly pure product, quite unlike the crude
material commonly used in the 19th century and at the beginning of the 20th
century. The aniline used today seems to be non-carcinogenic; but it is possible
that the crude aniline of the last century may have contained a carcinogenic
impurity, possibly 4-aminodiphenyl (Walpole, Williams and Roberts,. 1952).
The original observations of Rehn referred to the manufacture of fuchsine
(magenta); but workers engaged in the manufacture of other dyestuffs and
intermediates have also been shown to be especially liable to cancer ofthe bladder.
There have been many attempts to identify the carcinogens involved and until
recently there have been some differences of opinion on the matter.
Recent statistical surveys have demonstrated that contact with benzidine,
1-naphthylamine and 2-naphthylamine, in either manufacture or use, can cause
bladder tumours (Case, Hoskar, McDonald and Pearson, 1954; Case and Pearson,
1954; Goldblatt, 1949; Scott, 1952; Barsotti and Vigliani, 1952). It seems
that 2-naphthylamine has been the most potent cause of occupational bladder
tumours between 1915 and 1951, the average induction period being 16 years. A
similar averageinductionperiod was foundforbenzidine, that for 1-naphthylamine
being 22 years. Among certain groups of men the hazard is very high and one in
five mayexpect to develop bladder tumours. The manufacture of2-naphthylamine
has accordingly been discontinued by many of the major chemical companies.
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The manufacture of fuchsine (magenta) and of auramine also produces an
occupational hazard of the same nature, but the available data do not indicate
whether an intermediate or the final product is involved in tumour production.
For many years all attempts to confirm the carcinogenic activity of various
aromatic amines by experimental tests in laboratory animals were without positive
result (see, for example, Berenblum and Bonser, 1937). In some cases the experi-
ments were of insufficient duration; in others, non-susceptible animals were used.
In 1938, however, Hueper, Wiley and Wolfe obtained bladder tumours in dogs
following administration of commercial 2-naphthylamine. A few years later
Bonser (1943) obtained epithelial tumours ofthe bladder in dogs following massive
oral administration of a purified 2-naphthylamine over a period of five years.
Bladder tumours have also been obtained in mice, rats and in rabbits, but these
species are far less susceptible, and in the case of rats and rabbits only benign
tumnours were obtained (Bonser, Clayson, Jull and Pyrah, 1952; Bonser, Clayson
and Jull, 1951). Experimental bladder tumours have not been induced with
1-naphthylamine. Benzidine, however, has been shown to produce bladder
tumours (with difficulty) in the dog, and it has induced tumours at a number of
sites following administration to rats (Spitz, Maguigan and Dobriner, 1950;
Walpole, Williams and Roberts, 1954).
Detailed examination of aromatic amines
The aromatic amines have not been as extensively investigated as the poly-
cyclic hydrocarbons, but it is already clear that many compounds of this nature
possess carcinogenic activity.
Although dyestuffs-intermediates are of prime interest in this field, much of
the recent work has stemmed from the discovery that the insecticide 2-acetyl-
aminofluorene (I) is a potent carcinogen (Wilson, DeEds and Cox, 1941). When
incorporated into the diet of rats it produced multiple tumours including those of
the liver, bladder, breast and auditory canal. The minimum effective concentra-
tion in the diet was found to be 0.004 per cent, the maximum tolerated being
0.125 per cent. The latter dose produced tumours in a very short time, but the
mortality was high. A daily dose of4 mg. given for 25 weeks was found to produce
tumours in more than 90 per cent ofthe animals in 42 weeks or less (Bielschowsky,
1944a, 1947; Dunning, Curtis and Madsen, 1947).
NH.COCH3
The distribution of tumours in the various organs has been shown to vary
considerably with the sex and strain of the rat under test (Harris, 1947), and the
distribution can also be affected by other factors. Bielschowsky (1944b) found
tilat although tumours of the thyroid are not produced by 2-acetylaminofluorene
alone, such neoplasms are common when it is administered together with a
goitrogenic substance such as allyl thiourea, or methyl thiouracil (Hall, 1948).
Similarly, thyroid tumours were produced by feeding 2-acetylaminofluorene
for 13-25 weeks to partially thyroidectomized rats (Bielschowsky, 1949). Complete
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thyroidectomy prior to the administration of 2-acetylaminofluorene prevents the
development of neoplasms of the liver; but tumours were observed in several
other organs, the most frequently affected site being the meatus acousticus externus
(Bielschowsky and Hall, 1953). (It should be noted that thyroid adenomata
have also been observed following prolonged administration of goitrogenic
substances (allyl thiourea and thiourea) alone (Bielschowsky, 1945a; Purves and
Griesbach, 1947), and the prolonged administration of thiourea and of thioaceta-
mide is also reported to produce liver tumoufrs (Fitzhugh and Nelson, 1948;
Dupta, 1955).)
The influence of sex hormones on the distribution of tumours has also been
studied. The incidence of mammary carcinoma was not increased by the simul-
taneous administration of 2-acetylaminofluorene and oestrogen, but it was
increased enormously when progesterone was substituted for the oestrogen
(Kirby, 1947; Cantarow, Stasney and Paschkis, 1948).
2-Acetylaminofluorene has also been shown to be a carcinogen when given to
several different strains of mice, but this species was found to be more resistant
than the rat (Armstrong and Bonser, 1944, 1947; Foulds, 1947; Wilson, DeEds
and Cox, 1947a). Here again strain differences were found to be important. For
example, of five strains of mice tested, the CBA strain showed the greatest
susceptibility to bladder tumours.
Some interesting metabolic studies have been reported using 2-acetylamino-
fluorene labelled with C14 in the terminal carbon atom of the acetyl group. With
this compound, 6 per cent of the administered radioactivity was eliminated in
the breath of rats within six hours. On the other hand there was a negligible
amount of activity in the breath following administration of the 9-C14 labelled
compound. It seems likely that part at least of the administered 2-acetylamino-
fluorene may be hydrolysed in vivo, the acetyl residue being metabolised inde-
pendently of the remainder of the molecule (Morris, Weisburger and Weisburger,
1950). It is not surprising, therefore, that the parent amine, 2-aminofluorene,
also produced multiple tumours in both rats and mice receiving it in the diet;
but it does seem to be less effective than the acetyl derivative (Wilson, DeEds
and Cox, 1947b). When administered to rats by skin-painting in acetone solution,
all the animals developed liver tumours by 280 days, and one had a tumour ofthe
ductus acusticus externus; but no skin cancers were produced (Bielschowsky,
1944a). With mice, only one tumour appeared at the site ofpainting in a total of
28 mice surviving more than 200 days (Kirby, 1948). Mice receiving the parent
amine by injection showed a low incidence of tumours at the site of injection, in
the liver, bladder, kidney, mammary gland and ovary.
Several closely related compounds have also been tested, including 2-diacetyl-
aminofluorene 2-monomethylaminofluorene, 2-dimethylaminofluorene and 7-
fluoro-2-acetylaminofluorene. All these compounds are active, but they are less
active than 2-acetylaminofluorene, and in general they are less effective in produc-
ing multiple tumours. 2-Acetylamino-7-hydroxyfluorene, which is a metabolite
of 2-acetylaminofluorene, proved to be inactive (Bielschowsky, 1954b, 1947).
Fluorene itselfis also inactive, but 2-nitrofluorene is active and it seems likely that
it is reduced in vivo to 2-aminofluorene.
Other closely related compounds include the heterocyclic derivatives 3-acetyl-
aminodibenzothiophen (II), 3-acetylaminodibenzothiophen-5-oxide (III), and
3-acetylaminodibenzofuran (IV). None of these compounds produced cancers of
23
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the liver, but 3-acetylaminodibenzothiophen (II) was found to be as effective as
2-acetylaminofluorene in inducing cancers in the mammary gland and in ear duct
tissue. The remaining two compounds (III and IV) proved somewhat less effective
in this respect (Miller, Miller, Sandin, and Brown, 1949).
0o
NH~~~~~~~~~~s N.CoCH
NH.COCH3 S NH.COCH3
IIm
j jjf\ NH.COCH3
These differences in the distribution of the tumours are unlikely to be of
fundamental importance. As Clayson (1953) has pointed out, the widespread
distribution of tumours produced by compounds of the acetylamninofluorene
type suggests that the active agents circulate and induce tumours where their
concentration and other factors are favourable. Small differences in chemical
structure can easily affect the way in which the substance circulates. Moreover,
as mentioned above 2-acetylaminofluorene produces tumours of the thyroid of
the rat onlywhen thisgland is stimulated by agoitrogenic agent or byother means.
In these compounds, the -CH2- bridge which occurs in 2-acetylaminofluorene
has been replaced by a hetero-atom; but a bridge is not essential for carcinogenic
activity. 4-Aminodiphenyl (V) has been shown to be a potent carcinogen in the
rat when administered by subcutaneous injection, producing tumours at a
variety of sites (Walpole, Williams and Roberts, 1952). Moreover, it produces
bladder tumours in dogs receiving the material by mouth (Walpole, Williams
and Roberts, 1954, 1955). Similarly, 3: 2'-dimethyl-4-aminodiphenyl (VI) has
been found to be even more potent than 4-aminodiphenyl in the rat (Walpole,
Williams and Roberts, 1952); and 4-dimethylaminodiphenyl (VII) produced
tumours in the mammary glands, ear duct, liver and vertebral canal of male rats
(Miller, Miller, Sandin and Brown, 1949).
NH2 NH2
YV~ u~VI
N3N(CH3)2
VII
It is of some interest that 4-acetylaminodiphenyl produces tumours in the
mammary gland and ear duct in female rats, but is inactive in males. 2-Methyl-
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4-acetylaminodiphenyl (VIII) and 2'-methyl-4-acetylaminodiphenyl (IX) are
inactive in rats of both sexes (Sandin, Melby, Hay, Jones, Miller andMiller, 1952).
CH32CH
NH.COCH3 2H.C OCH3
__i IX
F NH2
X
As 4-aminodiphenyl is largely metabolised to the 4'-hydroxy derivative, the
testing of a derivative in which the 4'-position is blocked was clearly of interest.
Hendry, Matthews, Walpole and Williams (1955) therefore examined 4'-fluoro-4-
aminodiphenyl (X) and found it to be more active than the parent amine.
However, the introduction of the fluoro-substituent also produced a profound
change in the pattern of tumour incidence. With 4-aminodiphenyl itself the
commonest tumours were intestinal; but with the 4'-fluoro- derivative, tumours
appeared predominantly in the liver and kidney.
Aromatic amines of some other types are also cancer producing. 2-Amino-
anthracene (XI) is closely related to 2-aminofluorene, and it has produced liver
tumours in mice receiving the compound by subcutaneous injection (Shear, 1938).
Tumours of the skin have also been produced in rats following prolonged skin-
painting with an acetone solution (Bielschowsky, 1946).
~Jx~ ~NH2
NH.COCH3
XI XII
2-Acetylaminophenanthrene (XII) has produced tumours of the mammary
gland, ear duct, and intestinal epithelium, and also showed a moderate leukemo-
genic activity. 3-Acetylaminophenanthrene also produced tumours of the mam-
mary gland, ear duct and small intestine (Miller, Sandin, Miller and Rusch, 1955).
All these amines are, of course, also related to benzidine (XIII), which has
been proved to be a bladder carcinogen for man, which produces bladder tumours
in the dog, and which gives a variety of tumours in the rat (Spitz, Maguigan and
Dobriner, 1950; Walpole; Williams and Roberts, 1954). 3: 3'-Dihydroxy-
benzidine (XIV), a probable metabolite of benzidine, is also carcinogenic to rats
and mice (Baker, 1950, 1953).
The aminostilbenes represent yet another type of carcinogenic amine.
Relatively few members of this group have been tested for carcinogenic activity,
having been chiefly studied for their growth-inhibitory activity. However,
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H2N NH2
xm
HO2 H OH
H,N NH-2
MYV
CH=CH NH2
Xv
4-aminostilbene (XV), 4-dimethylaminostilbene, 4-dimethylamino-2'-methylstil-
bene and 1-(4'-dimethylaminophenyl)-2-(1'-naphthyl)ethylene have been found
to produce a wide variety of tumours in rats when administered by subcutaneous
injection. In mice the compounds were found to be far less active (Haddow,
Harris, Kon and Roe, 1948).
To conclude this section, it seems that although the carcinogenic aromatic
amines are ofrather diverse structure, the requirements for activity are becoming
clearer. For example, among the derivatives and analogues of 2-acetylamino-
fluorene the structural requirements for activity against the liver are summarised
in the following chart which is due to Miller, Sandin, Miller and Rusch (1955).
Inact
-CHOH-
Inactive if
-S-
-SO-
-O-
-CH=CH-
-CH2-CH2-
-H H-
-SO2-
-NH
L NH.COCH3
Active if
-NH2
-NHCH3
-NO2
-N(CH3)2
Inactive if
-H
-C1
This summary would appear to indicate that a fluorene nucleus is essential
for strong carcinogenic activity towards the liver; but ifother structural features
are also changed, this would not seem to be true. 4'-Fluoro-4-aminodiphenyl
does produce tumours of the liver, and in this connection it is noteworthy that
-H
Active at
sites other
than liver
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7-fiuoro-2-acetylaminofiuorene is much more active towards the liver ofboth male
and female rats than 2-acetylaminofluorene. It is reasonable to conclude therefore
that certain structural features may profoundly affect the distribution of the
compound in the animal body and hence the distribution of tumours. On the
other hand, these same structural features may have little or no effect in governing
whether a certain substance is actually carcinogenic or not.
It has been suggested that the greater carcinogenic activity of derivatives of
fluorene versus diphenyl derivatives is associated with the -CH2- bridge which
helps to maintain a coplanar arrangement of the benzene nuclei (Miller, Miller,
Sandin and Brown, 1949; Sandin et al., 1952). In this connection attention has
been called to the striking difference in the incidence and distribution of tumours
produced by 2-acetylaminofluorene, and 4-acetylaminodiphenyl, and the lack
of activity in 2-methyl-4-acetylaminodiphenyl and 2'-methyl-4-acetylamino-
diphenyl (Table I). Spectrographic evidence confirms the suggestion thatplanarity
is greater in 2-acetylaminofluorene than in 4-acetylaminodiphenyl, and it also
indicates that the two methyl derivatives are less planar than 4-acetylamino-
diphenyl itself.
TABLE I.*-Carcinogenic Activities of 2-Acetylaminofltuorene and Certain
Diphenyl Derivatives.t
Number of rats with tumours in
Number A
of rats Mammary Small
Compound. Sex. studied. Liver. gland. Ear duct. intestine.
2-Acetylaminofluorene . M . 26 . 22 0 10 13
F . 25 . 0 21 20 5
4-Acetylaminodiphenyl . M . 15 . 0 0 0 0
F . 15 . 0 11 2 0
2-Methyl-4-
acetylaminodiphenyl . M . 9 . 0 0 0 0
F . 9 . 0 0 0 0
2'-Methyl-4-
acetylaminodiphenyl . . M . 9 . 0 0 0 0
F . 9 . 0 0 0 0
*Sandin et al. (1952).
t Final tumour incidences in rats fed 1 62 m. moles of compound per kg. of a grain diet for 8
months and the grain diet alone for an additional 2 months.
Nevertheless planarity cannot be a sole determining factor for pronounced
activity, and in particular for activity against the liver, for the methyl derivative,
3: 2'-dimethyl-4-aminodiphenyl, in which there is just as much restriction to
planarity, is more active than 4-aminodiphenyl itself. Moreover, as mentioned
above, the introduction of a fluoro-substituent seems to increase the activity,
particularly towards the liver, and this substitution can have little effect on the
planarity of the molecule.
Metabolism of aromatic amines
When 2-naphthylamine (XVI) is administered to dogs it is oxidised to 2-amino-
l-naphthol (XVII) and excreted as ethereal sulphate (XVIII) (Wiley, 1938;
Bonser, Clayson and Jull, 1951).
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OH OSO3H
NH2 [H,I NHN2
XVI XVII XVIII
In rats, rabbits and monkeys, however, the administration of 2-naphthylamine
by subcutaneous injection was found to be followed by the excretion in the urine
of 2-acetylaminonaphthalene and 2-acetylamino-6-hydroxynaphthalene, together
with unchanged amine (Dobriner, Hofmann and Rhoads, 1941). Subsequently,
it has been found that some 2-naphthylamine-l-sulphuric acid is also excreted by
rats. It has also been found that administration of 2-acetylaminonaphthalene to
rats by subcutaneous injection, is followed by the excretion of 2-acetylamino-
6-hydroxynaphthalene (Manson and Young, 1950).
These metabolic transformations of2-naphthylamine in the rat are summarised
in the following chart in which conversions which have been shown to take place
are indicated by solid arrows. Possible intermediary reactions are indicated by
broken arrows.
OH
COCH3
It seems, therefore, that 2-naphthylamine is metabolised by two distinct
routes in laboratory animals, one leading to a 2-amino-l-naphthol derivative, and
the other to a 2-amino-6-naphthol derivative. Clayson (1950) has developed a
method for the estimation of 2-amino-1-naphthol conjugates in the urine, and
Bonser, Clayson and Jull (1951) have used the procedure to determine the urinary
excretion ofthe amine in different species. The results are summarised in Table II.
It seems that there is an approximate correlation between thetumour-suscepti-
bility of the species and the amount of 2-amino-1-naphthol conjugate excreted.
The dog, which is particularly susceptible to 2-naphthylamine carcinogenesis
excretes a high percentage of the dose as 2-amino-1-naphthol conjugates. On the
other hand, the mouse, rat and rabbit, which are less susceptible, excrete smaller
quantities in this form.
Bonser, Clayson and Jull concluded that 2-amino-1-naphthol is the actual
carcinogen and that the parent amine, 2-naphthylamine, is without direct activity.
2-Aminno-l-naphthol hydrochloride was accordingly tested as a local carcinogen
using a method involving the surgical introduction ofparaffin wax pellets contain-
ingthe material intothe lumen ofthe bladder ofthe mouse. Underthese conditions
2-amino-1-naphthol hydrochloride proved to be an active carcinogen of the same
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TABLE II.-Excretion of 2-amino-1-naphthol Conjugates in
Urine of Various Species*
Recovery
of metabolite
Dose Route of (percentage
Species. (mg/kg.). administration. of dose).
Dog . . . 30 . By mouth . 55-70
120 . ,, ,, . 30-45
Cat . . . 50 . ,, ,, . 30-50
Mouse . . 120 . ,, ,, . 20-40
Rat . . . 25 . Intraperitoneal . 6-9t
150 . ,, 12-15t
Rabbit . . 200 . By mouth . about 5
*Bonser, Clayson and Jull (1951).
t The lower value was obtained in rats given a high-protein (20 per cent) diet, and the higher
value in rats given a low-protein (5 per cent) diet.
order ofpotency as methylcholanthrene; but 2-naphthylamine itselfproved to be
inactive whentestedin thisway. Moreover, the subcutaneousinjection of2-amino-
1-naphthol hydrochloride in oil has given a few sarcomas in mice and rats (Bonser,
Clayson, Jull and Pyrah, 1952). (It may be noted that the rat is not a suitable
telt animalforinvestigations involvingimplantation ofwaxpelletsintothebladder.
Paraffin wax itself can cause tumours in the bladder of this species (Bonser,
Clayson, Jull and Pyrah, 1953).)
Largely on the basis ofthese results, it has been suggested that all carcinogenic
amines may owe their activity to the fact that they are converted, at least in part,
to ortho-hydroxyamines (Walpole, Williams and Roberts, 1952; Clayson, 1953).
Certain structural features, as well as the species ofanimal under test, may affect
the proportion of ortho-hydroxyamine formed, and may therefore be of prime
importance. For example, it has been suggested that those aromatic amines which
have a blocked para position will tend to hydroxylate to a greater extent in the
ortho- position, and thus give rise to carcinogenic substances. Furthermore it
may well be that 1-plfenylazo-2-naphthol (XIX) and 1-o-tolylazo-2-naphthol
(XX) are reduced in vivo'to 1-amino-2-naphthol, and this might account for the
undoubted carcinogenic activity of these food-colouring-matters in mice (Kirby
and Peacock, 1949; Bonser, Clayson and Jull, 1954).
XIX XX
In order to test this general hypothesis, 2-aminophenol, 3-amino-2-naphthol
hydrochloride, and 1-amino-2-naphthol-4-sulphonic acid (sodium salt) were
tested by the bladder-implantation technique in mice (British Empire Cancer
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Campaign, 1953) but were found to be inactive. An impure specimen of 1-amino-
2-naphthol hydrochloride didgivetumourshowever, as did 1-phenylazo-2-naphthol
and 4-hydroxy-3-aminodiphenyl hydrochloride.
Walpole, Williams and Roberts (1952) pointed out that the metabolic yield
of o-hydroxyamines is increased by o-methylation and by N: N-dimethylation,
and they therefore suggested that o-toluidine and dimethylaniline, but not aniline,
should produce bladder tumours in the dog. However, this suggestion has been
considerably weakened by the failure to confirm any local carcinogenic action with
o-aminophenol. Moreover, Druckney and Schmahl (1954) and Druckney, Schmahl
and Reiter (1954) have tested the three isomeric N: N-dimethyltoluidines in rats
in doses ofup to 10 g. per animal over the entire life span. No chronic toxic effects
were observed, the average life span was not dinlinished and no carcinogenic
activity was observed. Finally, 2-hydroxy-4-dimethylaminoazobenzene and
2'-hydroxy-4-dimethylaminoazobenzene, both ofwhich would be expected to give
o-hydroxyamines on metabolic reduction of the azo- group, have failed to give
tumours (Badger, and Lewis, 1952).
Further work is clearly necessary in order to test this interesting hypothesis.
In support it may be noted that although 2-amino-7-hydroxyfiuorene has been
identified as a metabolite of 2-acetylaminofluorene in rats (Bielschowsky, 1945b)
in recent work using carrier techniques, 1-hydroxy-, 3-hydroxy-, and 5-hydroxy-
2-acetylaminofluorene have also been identified as metabolites in the urine of
rats fed 2-acetylaminofiuorene-9-Cl4 (Weisburger and Weisburger, 1954, 1955).
The testing ofthese substances as local carcinogens will therefore be awaited with
interest. Similarly 2-hydroxy-3-acetylaminofiuorene has been found to be a
metabolite of 3-acetylaminofluorene in the rat (Weisburger, 1955).
Furthermore, benzidine seems to be metabolised to 3-hydroxybenzidine and
4: 4'-diamino-3-diphenylyl hydrogen sulphate in the dog (British Empire Cancer
Campaign, 1954, p. 223; Bradshaw and Clayson, 1955). In humans it is meta-
bolised, at least in part, to 3: 3'-dihydroxybenzidine, and when fed to rats this
metabolite rapidly produced intestinal tumours (Baker, 1950, 1953; Adler, 1908;
Walpole, Williams and Roberts, 1952). On the other hand, 3: 3'-dihydroxy-
benzidine proved inactive when tested by the bladder-implantation technique in
in mice (British Empire Cancer Campaign, 1953) so the significance of the former
result is in some doubt.
In dogs, 4-aminodiphenyl is metabolised to 4-amino-3-diphenyly] hydrogen
sulphate. When the urine was hydrolysed by boiling with acid, 3-hydroxy-4-
aminodiphenyl was identified (Bradshaw and Clayson, 1955). All these reports
therefore support the view that ortho-hydroxylation is of considerable importance
in the carcinogenic process.
CHOLESTEROL AND RELATED COMPOUNDS
Although the discovery of 3: 4-benzopyrene and of other similar carcinogens
has done much to explain the incidence of some occupational and environmental
cancers, the great majority of human cancers remain "spontaneous" and unex-
plained. In this connection the hypothesis that a chemical carcinogen may be
formed in vivo by some abnormal mechanism should clearly be investigated, and
work has proceeded along several different lines.
In 1932 Kennaway and Cook suggested that a polycyclic aromatic hydrocarbon
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might arise from certain steroids by some abnormal mechanism. Soon afterwards,
20-methylcholanthrene was prepared from deoxycholic acid, albeit by laboratory
methods (Cook, 1933; Cook andHaslewood, 1933, 1934, 1935; Wieland andDane,
1933), and this 1: 2-benzanthracene derivative was soon found to be a very
potent carcinogen (Barry et al., 1935).
Methylcholanthrene has also been prepared from cholic acid and from chole-
sterol; but there is no evidence that transformations of this type do in fact
proceed in vivo. At the moment, this work must be considered solely as an interest-
ing speculation. There is, however, some evidence that deoxycholic acid itself is
carcinogenic when given to mice by injection in sesame oil (Badger, Cook, Hewett,
Kennaway, Kennaway and Martin, 1942).
Another suggestion has been that polycyclic aromatic hydrocarbons might
arise from steroids, etc., during the cooking of food, and this hypothesis has also
been examined (Peacock, 1947). A carcinogenic tar has certainly been produced
bythe pyrolysis ofcholesterol (Kennaway andSampson, 1928), butthetemperature
involved was much greater than could occur in cooking. More recently, Falk,
Goldfein and Steiner (1949) have studied the pyrolysis of cholesterol at 360°, and
the following compounds were identified: cholestenone, dicholesteryl ether,
3: 5-cholestadiene, the naphthalene derivative of cholesterol, the phenanthrene
derivative of cholesterol, methylcyclopentenophenanthrene and chrysene. Except
for cholestenone, all these products may be considered as intermediates in the
transformation of cholesterol to methylcholanthrene; but the latter compound
was not found.
An investigation of a different kind was initiated by Hieger (1946, 1947, 1949)
who has shown that cholesterol (XXI) has definite if weak carcinogenic activity.
The first experiments were carried out using a commercial cholesterol, which gave
25 sarcomas in 436 mice. Subsequently, however, it was found that purified
cholesterol is also cancer-producing (Hieger and Orr, ]1954).
Fieser (1954) has pointed out that as the total quantity ofcholesterol in a man
weighing 65 kg. is approximately 210 g., or 0.3 per cent of the wet weight, it is
unlikely that it can have the properties of a carcinogen. He suggested that the
observed activity must be due to a transformation product. In this connection
it is noteworthy that a crude progesterone preparation, prepared by permanganate
oxidation of cholesterol dibromide, and debroniination, produced tumours in
32 per cent of the mice tested (Bischoff and Rupp, 1946; Spielman and Meyer,
1939).
Reasoning in terms of the chemical reactivity required for carcinogenic
activity, Fieser (1954) suggested that A5-cholestene-3-one (XXII) might be the
true carcinogen formed from cholesterol. It has recently been found (Fieser,
Greene, Bischoff, Lopez and Rupp, 1955) that the hydroperoxide (XXIII) derived
from this compound is an active carcinogen. This hydroperoxide, 6f/-hydroperoxy-
J4-cholestene-3-one (XXIII), was given by subcutaneous injection to 32 mice,
and at the age of 12 months fibrosarcomas had appeared at the site of injection in
13 of the mice treated (average tumour age, 9.6 months) and 17 of the remaining
mice were still alive. Fieser's views on the chemical reactivity requirements
for carcinogenic activity have therefore been supported in a very satisfactory
way, and further work in this field will be awaited with interest. It may be added
that there is some indirect evidence that A5-cholestene-3-one can be formed from
cholesterol in the body.
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XXI ~~~xXI
OOH
XXIII
ALKYLATING AGENTS
Nitrogen and sulphur mustards
Various war-time studies showed that the nitrogen and sulphur mustards
resemble ionizing radiations in many of their biological effects, particularly in
regard to the inhibition of cell division and growth, the production of mutations
and chromosome damage. Compounds of this nature have accordingly been
extensively investigated as it was hoped that an effective tumour-inhibitor might
be found. A few have also been tested for carcinogenic activity.
The nitrogen mustards do not seem to be carcinogenic to the skin of mice
(Fell and Allsopp, 1948; Narpozzi, 1953); but they produce tumours rather
slowly when administered by injection (Boyland and Horning, 1949; Griffin,
Brandt and Tatum, 1950, 1951).
CH2. CH2. C1 CH2. CH2. C1
/ /
HN C1. CH2. CH2. N
CH2. CH2. C1 CH2. CH2. Cl
XXIV XXV
CH2 . CH2. C1
/
S
CH2 . CH2 . C1
XXVI
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Boyland and Horning used two groups of twenty stock mice. One group was
given an aqueous solution ofmethyl di(2-choroethyl)-amine hydrochloride (XXIV)
by subcutaneous injection and received 1.0 mg./kg. at weekly intervals for 50
weeks. The second group received a similar injection of tri(2-chloroethyl)amine
hydrochloride (XXV); but the injections were stopped after 10 weeks as only 4
mice remained alive. Of the 14 mice from the two groups which survived more
than 250 days, 10 had tumours. These included lung tumours (8), lymphosarcomas
(2), a uterine fibromyoma and a spindle-celled sarcoma at the site of injection.
In strain A mice, Heston (1949) obtained tumours after 16 weeks in 100 per
cent of the animals receiving a total dose of 0.1 mg. of methyl di(2-chloroethyl)
amine hydrochloride. Sulphur mustard (XXVI) has also been shown to give lung
tumours in a high percentage of the mice receiving the material by subcutaneous
injection (Heston, 1950, 1953), and it is also carcinogenic in the rat (Haddow,
1953).
Few aromatic mustards seem to have been tested, but Haddow (1953) has
reported that pronounced carcinogenic activity (mainly after subcutaneous
injection, but also following feeding) has been shown by several compounds
(XXVII-XXXI) of this type.
N(CH2CH2C1)2
N(CH2CH2C1)2 CH3 N(CH2CH2C!)2
XXXV Xxv XIX
CH3
NC C 21 fN(CH2CH2C')2jN(CH2C C1)2
XXX XXXI
The mustards are rather reactive substances, especially in polar solvents.
They react with water, with anions and with bases, and in general they can be
described as powerful alkylating agents for functional groups such as -OH,
-NH2, etc. As such functional groups occur in nucleic acids, in enzymes, and in
other important constituents of the cell, the biological activity of the mustards
may be intimatelyrelatedwith their chemical reactivity towards such centres. In
this connection it may be noted that Ross (1949, 1953) found that there is a good
correlation between the rates of hydrolysis of a series of di(2-chloroethyl)amines,
R.N(CH2CH2C1)2, and their activity as tumour inhibitors, the most reactive
substances being the most active tumour-inhibitors.
The inductive effect of the hetero-atom would be expected to facilitate the
removalofthehalogen atomto givethe carbonium ion (XXXIII), andconsiderable
evidence has accumulated to indicate that this ion is, in fact, the reacting species
(Ross, 1953; Alexander, 1954). Withaliphatic (butnotwitharomatic)derivatives,
this carbonium ion may be stabilised by passing into the cyclic ethyleneimonium
ion (XXXIV).
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CH2
R2.N.CH2CH2C1I R2N.CH2CH2 + 2 + C1- R2.N+' C1-
CH2
XXXII XXXIII XXXIV
Proof that ionisation does occur was provided by Seligman, Rutenberg and
Friedman (1949) who administered diethyl (2-iodoethyl)amine-1131. The resulting
radioactivity pattern was found to be almost identical with that shown following
administration of radioactive sodium iodide.
This picture of the nitrogen and sulphur mustards as biological alkylating
agents suggested that other alkylating agents might also possess similar biological
actions. An hypothesis (Goldacre, Loveless and Ross, 1949) that the action
might be associated with a cross-linkage reaction directed attention to known
cross-linking agents fortextile fibres; but subsequent work has shown that some
mono-functional alkylating agents have carcinogenic activity.
In these groups of alkylating agents the following structural features appear
to be the significant ones:
-S . CH2CH2C1 . . . sulphur mustard
> N . CH2CH2C1 . . . nitrogen mustards
-CH-CH2 . . . epoxides
/
0
CH2
-N . . . ethylene imines
CH2
-CH2 . O . SO2CH3 . methane sulphonates.
Ethyleneimine derivatives
Several N-substituted ethyleneimine derivatives have been tested for carcino-
genic activity in both mice and rats (Walpole, Roberts, Rose, Hendry and Homer,
1954), and the results are summarised in Table III.
The compounds were generally tested by subcutaneous injection of their
solutions in arachis 'oil, but the doses and frequencies of injection were not
standardised, and it is therefore difficult to assign accurate relative potencies. It
seemshoweverthatethyleneimine (XXXV) itselfis carcinogenic and thata number
of acylethyleneimines (XXXVI) are likewise active. The most potent compounds
produced tumours in a high percentage of the rats tested after a latent period
of about five months.
CH2 CH2 CH2
HN< R CO. N R S02 . N
CH2 CH2 OH2
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TABLE III.-Carcinogenic Activity ofEthyleneimine Derivatives.*
Carcinogenic activity.t
Compound. Compound.
Ethyleneimine
CH2
HN<I
CH2
Acetylethyleneimine
CH2
CH3CO .NKI .
CH2
Butyrylethyleneimine
CH2
CH3(CH2)2 . CO. N< H
CH2
Caproylethyleneimine
CH2
CH3(CH2)4 . CO . N7
CH2
Nonanoylethyleneimine
CH2
CH3(CH2)7 . CO . N7
CH2
Lauroylethyleneimine
CH2
CH3(CH2)10 . CO. N7
CR2
Myristoylethyleneimine
CH2
CH3(CH2)12 . CO. N< \
CH2
Stearoylethyleneimine
CH2
CH3(CH2)16 . CO . N<
CH2
Mice. Rats.
* - * ++
* * + ++
* * i ++
* * ± ±+
* * + ++
* * *- +
CH2
CHR(CH2)7 . CH = CH (CH2)7 . CO N<I
CH2
N: N-Dimethylstearamide
CH3
CH3(CH2)16 . CO . N<
CH3
* Walpole, Roberts, Rose, Hendry and Homer (1954).
t Dissolved in arachis oil and injected subcutaneously.
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Some attempt was also made to test the analogous ethyleneiminosulphonyl
alkanes (XXXVII), but the three compounds tested (R C7H15, C5H1 andC3H7)
all proved to be inactive.
/CH-z
CH2,2
Nl N H H- N~
/I
ci~~~~~~~~ N'/
tf--N ~CHz-N 2hN ph,~N5~~~~~~
CH2-CH2
XXXVIII XXXIX
A few ethyleneimine derivatives of a different type hae also been tested. For
example, the heterocyclic compound (XXXVIII) was found to be a very potent
carcinogen when tested by injection into rats (Walpole, Roberts, Rose, Hendry
and Homer, 1954). Triethylenemelamine (trisethyleneimino-8-triazine, XXXIX)
has been found to induce multiple pulmonary tumours in Strain A mice (Shimkin,
1954), but it seems to beinactive in stock mice (Hendry, Homer, Rose andWalpole,
1951). On the other hand it gives sarcomas at the site of injection in rats and,
indeed, is very potent in this respect (Walpole, Roberts, Rose, Hendry and Homer,
1954). Moreover, Roe and Salaman (1955) have found that it has an initiating
action on the skin ofmice, tumours being produced by subsequent treatment with
a promoting agent (croton oil).
It has been suggested (Walpole, Roberts, Rose, Hendry and Homer, 1954)
that ethyleneimine may be regarded as the ultimate carcinogen, the function of
the acyl group being merely to modulate chemical reactivity and to provide an
electrically neutral derivative capable ofdiffusing readily into the cell. The com-
pounds may be regarded as alkylating agents and the following general scheme
may serve as a basis for further work:
CH2
R NK] + Cell-H -H Cell- CH2CH2NHR
'CH2
On the other hand, the same authors have found that the three-membered
ring system is not essential for carcinogenic activity as N, N-dimethylstearamide
(XL) has some carcinogenic activity. However, it is less active than the corre-
sponding cyclic compound, stearoylethyleneimine.
.CH3
CH3(CH2)16 . CO . N\
CH3
XL
Trimethylolmelamine
Polymethylolamides have been used to modify the mechanical properties of
textile fibres, and a number of such substances were therefore submitted for test
as tumour-inhibiting agents.
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NH.CH20H
N N
HOCH2.HN)1NNNH.CH2OH
XLI
Trimethylolmelamine (XLI) has been tested as a carcinogen in mice and rats
(Hendry, Rose and Walpole, 1951). Subcutaneous injection into stock mice
resulted, after nine months, in one lymphoid leukaemia, no other mouse showing
any sign of malignant disease. Of the 30 rats injected, one developed a highly
malignant adenocarcinoma, one a spindle-celled sarcoma at the site of injection,
and one developed a lymphoid leukaemia. The authors point out that these
tumours may have been spontaneous and do not regard the above results as
unequivocal evidence for carcinogenic activity.
Bis-Epoxides
Following the cross-linking hypothesis of Goldacre, Loveless and Ross (1949)
bis-epoxides were found to possess the tumour-inhibiting activity and to produce
the chromosome abnormalities characteristic of the mustards. Only two com-
pounds ofthis type seem to have been tested for carcinogenic activity.
0\
CH-CH CH2-CH-CH-CH2
0 0
XLII XLIII
Vinyl cyclohexane dioxide (XLII) has been reported to be a carcinogen for
both mice and rats (Hendry, Homer, Rose and Walpole, 1951). This substance
was administered to rats by intraperitoneal injection of its solution in arachis oil
and a mixed cell sarcoma was obtained in one animal at seven months. When
tested in mice by application to the skin, this dioxide seemed to be highly carcino-
genic. Of the 20 mice receiving the compound, nine developed malignant tumours
and two developed papillomata which regressed when the treatment was stopped.
However, Walpole, Roberts, Rose, Hendry and Homer (1954) have repeated the
experiment with a more highly purified sample of the diepoxide and have failed
to obtain tumours. In the circumstances the carcinogenicity ofvinyl cyclohexane
dioxide must remain in doubt.
Butadiene dioxide (XLIII) gave no tumours in mice (Hendry, Homer, Rose
and Walpole, 1951). A few tumours were observed in rats following intraperi-
toneal injection ofits solution in arachis oil. Here again, however, further experi-
ments are necessary to confirm the carcinogenic activity of this substance.
Propiolactone
Thesimplealiphaticcompoundpropiolactone (XLIV)wasfoundtobemutagenic
(Smith and Srb, 1951) and was therefore tested as a carcinogen. It gave a high
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yield of sarcomata following subcutaneous injection in rats and must be rated as
a moderately potent carcinogen (Walpole, Roberts, Rose, Hendry and Homer,
1954).
CH2-- CH2
0 CO
XLIV
RoeandSalaman (1955) found that itis notcarcinogenic tothe skinofthe mouse;
but they were able to show that it does have an initiating action. That is, treatment
with propiolactone, followed by croton oil, did produce tumours.
Methane Sulphonates
No complete report has appeared on the carcinogenic activity of compounds
of this type. It appears, however, that compounds of general formula (XLV)
and (XLVI) are active. 1: 4-Dimethanesulphonoxybutane is reported to be
outstanding in this respect (Haddow, 1953). Shimkin (1954) has found that it
does not increase the incidence of pulmonary tumours in strain A mice.
CH2CH2. 0 SO.2Ar
Ar . N\ CH3SO20 . (CH.2)n · 0 SOCH3
CHCH2 . O SO,Ar
XLV XLVI
OTHER ORGANIC CARCINOGENS
Senecio Alkaloids
Plants of the Senecio species are widely used by South African negroes for
mnedicinal purposes, and it seemed probable that this practice might have some
bearing onI the high incidence of primary liver cancer among these people. In
order to test this hypothesis, Cook, Duffy and Schoental (1950) administered
the crude alkaloids from Seneciojacobaea L. (the common ragwort) in the drinking
water, to albino rats. Liver tumours were observed in 3 rats which survived more
than eight months of the treatment.
Senecio jacobaea is not itself a native of South Africa, but the alkaloidal
constituents are similar to those found in the local species which are commonly
used by the natives. More recently, the pure alkaloids retrorsine and isatidine,
which are known to occur in South African Senecio plants, have also been shown
toproducelivertumours (Schoental, HeadandPeacock, 1954). Intheseexperiments
58 rats survived the treatment with retrorsine, isatidine or the mixed alkaloids
ofSeneciojacobaea for more than 10 months. Of these, 45 showed changes in the
liver ranging from hyperplasia to neoplasia. It is of some interest that tumours
were produced in animals receiving a fully adequate diet. A deficient diet of the
type known to favour tumour formation by the use of azo-dyes did not prove
favourable with the Senecio alkaloids.
The alkaloid seneciphylline, also isolated from Senecio jacobaea, has been
shown to produce liver tumours in fowls (British Empire Cancer Campaign, 1954,
p. 4).
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The chemistry of the senecio alkaloids (the structures of most being known
only imperfectly) has been reviewed by Leonard (1950).
Tannic acid
When injected subcutaneously in rats, tannic acid produces cirrhosis, hepa-
tomas and cholangiomas in the liver; but no local carcinogenic action could be
demonstrated (Korpassy and Kovacs, 1949; Korpassy and Mosonyi, 1950).
The carcinogenic action on the liver was found to be retarded by a high-casein-
low-fat diet, and accelereated bya low-casein high-fat diet (Korpassy andMosonyi,
1953).
Chloroform and carbon tetrachloride
The repeated oral administration of carbon tetrachloride in olive oil to mice
ofvarious strains has been shown to produce hepatomas in a very high percentage
of the animals treated (Edwards, 1941; Edwards and Dalton, 1942; Edwards,
Edwards, Heston and Dalton, 1942; Eschenbrenner and Miller, 1944).
Similarly the repeated oral administration of chloroform also produces
hepatomas and cirrhosis of the liver, provided the individual doses are large
enough to produce liver necrosis (Eschenbrenner and Miller, 1945).
These findings are of some importance in view of the widespread medical and
industrial use of these materials. It is noteworthy that some hepatic injury has
been reported in workers employed in the manufacture of carbon tetrachloride
insecticide and fire extinguisher bombs (Sassi and Paruccini, 1954).
The mode of action of these agents remains obscure but it seems that the
carcinogenic activity is completely unrelated to the narcotic activity.
Urethanes
The intraperitoneal injection of ethyl urethane (ethyl carbamate, XLVII)
has been markedly to increase the incidence of lung tumours in mice (Nettleship,
Henshaw and Meyer, 1943).
H2N. COOC2HA
XLVII
The effect has been found in all the strains of mice tested, but some strains
were found to be more susceptible than others. It seems that this susceptibility
parallels the susceptibility of the strain to spontaneous pulmonary tumours
(Larsen, 1946; Orr, 1947; Cowen, 1947). The effect is unrelatedtothe anaesthetic
action ofurethane, and a variety ofother hypnotics provedineffective inincreasing
the incidence of lung tumours. On the other hand a single anaesthetic dose of
urethane sometimes proved effective; moreover the induction period may be
as short as two months (Henshaw and Meyer, 1944).
Ethyl urethane has also been found to have a carcinogenic action in rats,
whether administered orally or by intraperitoneal injection (Jaff6, 1947; Guyer
and Claus, 1947). In both cases a high incidence oflung tumours was observed.
Other esters of carbamic acid have also been tested as pulmonary carcinogens,
but the ethyl ester seems to be the mostpotent. The relative potencies oftheethyl,
isopropyl and n-propyl esters, for example, were found to be of the order of 81,
4 and 1 respectively. Trichloroethyl carbamate was found to be slightly carcino-
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genic (and toxic); but the methyl-monochloroethyl-, n-butyl- and isoamyl
esters were found to be inactive at the dosage levels employed (Larsen, 1947).
The effect of alkyl substitution on the nitrogen atom has also been studied
(Larsen, 1948), and in general, changes of this type were found to decrease the
activity as pulmonary carcinogens. Ethyl N-methyl carbamate was found to be
much less effective than ethyl carbamate itself; and N,N-dialkylated derivatives
were slightly less effective than the mono-alkyl compounds. With the exception
of the N-isopropyl compound, activity decreased as the length of the alkyl group
was increased.
In addition to this carcinogenic action towards the lung, it has recently been
shown that urethane produces a pre-neoplastic change when applied to the skin
of mice. When applied alone to the skin it produces no local tumours; but when
such application is followed by treatment with a promoting agent (croton oil)
tumours are produced (Salaman and Roe, 1953; Roe and Salaman, 1954). This
tumour-initiating action of urethane can be inhibited by the simultaneous
administration of glycine and formate, two purine precursors (Roe, 1955). This
observation lends some support to the hypothesis that urethane acts by competing
with one or more of the precursors in purine synthesis, perhaps leading to an
unphysiological purine-like substance (Roe, 1955).
Dulcin
The synthetic sweetening agent Dulcin (p-phenetylurea, XLVIII) has some
structural similarities to the urethanes, but this is largely superficial.
NH.CONH2 C
OC2H5
XLVIII
Fitzhugh and Nelson (1950) have found that this substance produces liver
tumours in albino rats fed at dosage levels of 0.1 per cent and above. At 0 5 and
1 per cent, Dulcin retarded the growth rate, increased the mortality rate and
produced dark red spleens.
Polymers
In 1941 Turner found that sarcomas are produced in rats following the subcu-
taneous implantation of Bakelite disks. Of 9 rats which survived longer than
20 months, 4 developed sarcomas at the site of the disk. It has since been found
that several other natural and synthetic polymers can produce similar tumours:
these include cellophane, polyethylene, polyvinylchloride, polystyrene, polymethyl
methacrylate, polytetrafluoroethylene and e-polycaprolactam (Oppenheimer,
Oppenheimer and Stout, 1948, 1952, 1954; Druckrey and Schmahl, 1954;
Laskin, Robinson, and Weinmann, 1954).
The pure polymers seem to be as effective as the commerical products, and
benzene extracts of such polymers have produced no tumours. Implanted quartz
sand usually produced tumours; but glass was found to be ineffective.
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The carcinogenic activity of these polymers is somewhat surprising in view of
the stability of these materials. Nevertheless polymers do degrade slowly, and it
is not unreasonable to suppose that the resulting free radicals will react with
important cellular constituents (Oppenheimer, Oppenheimer, Danishefsky, Stout
and Eirich, 1955). The polymers do not seem to be very potent carcinogens,
producing tumours only after a long latent period. Nevertheless the observations
are of considerable importance in view of the use of various plastics in surgery.
SUMMARY
1. Chemical carcinogens other than the polycyclic aromatic hydrocarbons
and the azo-compounds, have been reviewed.
2. Inorganic carcinogens include derivatives of arsenic, beryllium, chromium,
cobalt, nickel and zinc.
3. Many aromatic amines are cancer-producing. It seems that small changes
in chemical structure may affect the distribution ofthe amine in the body andthus
alter the distribution of tumours produced. Hormonal influences also have a
profound effect on the distribution.
4. Ortho-hydroxylation of aromatic amines is of considerable importance in
the carcinogenic process; but not all o-hydroxyamines are cancer-producing.
5. Among the cholesterol derivatives, the recent discovery that 6,-hydro-
peroxy-A4-cholestene-3-one is a carcinogen is of considerable importance.
6. Nitrogen and sulphur mustards, ethyleneimine derivatives, methane
sulphonates and propiolactone appear to be carcinogenic; but the present
evidence is inconclusive in regard to trimethylolamine and the bis-epoxides.
7. Several Senecio alkaloids are active in producing cancer of the liver, and
tumours in the same organ are produced by tannic acid, chloroform, carbon
tetrachloride, and by the synthetic sweetening agent Dulcin.
8. Certain urethanes (especially ethyl urethane) produce lung tumours in
mice. Ethyl urethane has also been shown to have an initiating action on the
skin of mice.
9. Several natural and synthetic polymers produce sarcomas following
subcutaneous implantation.
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